| SCHEDULE OF EARNING PER SHARE |
The
Company computes net earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires
presentation of both basic and diluted net earnings per share (“EPS”) on the face of the statement of operations. Basic EPS
is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding
(denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using
the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock
price for the period is used in determining the number of shares assumed to be purchased from the exercise of warrants, convertible preferred
stock and convertible debentures. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.
SCHEDULE
OF EARNING PER SHARE
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
| |
|
Three
Months Ended June 30, |
|
|
Six
Months Ended June 30, |
|
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
| Net loss computation of basic and diluted net
loss per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(7,422,426 |
) |
|
|
(2,519,158 |
) |
|
$ |
(13,476,085 |
) |
|
$ |
(6,273,817 |
) |
| Less: Redemption of Series D Preferred Stock
deemed dividend |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,295,294 |
) |
| Less: Common stock deemed
dividend (inducement cost) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Net loss attributable
to common stockholders |
|
$ |
(7,422,426 |
) |
|
|
(2,519,158 |
) |
|
$ |
(13,476,085 |
) |
|
$ |
(7,569,111 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted
net loss per common share
|
|
$ |
(0.09 |
) |
|
|
(0.11 |
) |
|
|
(0.18 |
) |
|
|
(0.49 |
) |
|
Basic and diluted
weighted average common shares outstanding
|
|
|
81,605,285 |
|
|
|
22,209,152 |
|
|
|
74,638,153 |
|
|
|
15,440,558 |
|
|
| SCHEDULE OF POTENTIAL DILUTIVE SECURITIES |
Potentially
dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are
as follows as of June 30, (in common equivalent shares):
SCHEDULE
OF POTENTIAL DILUTIVE SECURITIES
| |
|
2021 |
|
|
2020 |
|
| Warrants |
|
|
16,516,562 |
|
|
|
21,925,102 |
|
| Series A & B Notes |
|
|
- |
|
|
|
213,105 |
|
| Options and restricted
stock units |
|
|
203,135 |
|
|
|
1,018,853 |
|
| Total anti-dilutive weighted average shares |
|
|
16,719,697 |
|
|
|
23,157,060 |
|
|